Klippel-trénaunay Syndrome
📧 Sign up to get email alerts when something new happens for Klippel-trénaunay Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-02-23Clinical Trial Update: National Evaluation of Patients With PIK3CA-Related Overgrowth Spectrum (PROS)
The PROS clinical trial (NCT05563831) has completed, providing an update on patients with PIK3CA-related overgrowth spectrum and related con…
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: A Phase 2 Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, in Adults and Children With PIK3CA Related Overgrowth Spectrum and Malformations Driven by PIK3CA Mutation [Phase 2]
Phase 2 clinical trial update for RLY-2608, a mutant-selective PI3Kα inhibitor, in adults and children with PIK3CA-related overgrowth spectr…
-
CLINICAL_TRIALS research · 2025-07-11Clinical Trial Update: Clinical and Paraclinical Characterization of Osseous Anomalies of the Long Bones of Patients With Klippel Trénaunay Syndrome [NA]
Clinical trial update describing the radiological and osseous characteristics of long bones in patients with Klippel-Trénaunay syndrome; the…
-
CLINICAL_TRIALS research · 2024-11-06Clinical Trial Update: Identification of Biomarkers for Patients with Vascular Anomalies
Update on a clinical trial investigating biomarkers in patients with vascular anomalies; the study is currently recruiting.